articleTop 1% cited
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
Gynecologic Oncology · 2004 · Vol. 94(3) · pp. 650–654
S. Dennis✉(Memorial Sloan Kettering Cancer Center)Corinna C. Franklin(Harvard University)Douglas A. Levine(Memorial Sloan Kettering Cancer Center)Faina Akselrod(Nassau University Medical Center)Paul Sabbatini(Memorial Sloan Kettering Cancer Center)William R. Jarnagin(Memorial Sloan Kettering Cancer Center)Ronald P. DeMatteo(Memorial Sloan Kettering Cancer Center)Elizabeth Poynor(Memorial Sloan Kettering Cancer Center)Nadeem R. Abu‐Rustum(Memorial Sloan Kettering Cancer Center)Richard R. Barakat(Memorial Sloan Kettering Cancer Center)
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesRenal cell carcinoma treatmentMedicineFallopian tubeOvarian cancerEpithelial ovarian cancerGynecologyFallopian tube cancerOncologyCancerInternal medicine
MeSH terms
AdultAgedAged, 80 and overFallopian Tube NeoplasmsFemaleHumansMiddle AgedNeoplasm StagingOvarian NeoplasmsPeritoneal Neoplasms
Citations
321
FWCI
17.78
field-weighted impact
References
22
Percentile
99%
vs. same field & year
Citations per year
Cited by
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer
Gynecologic Oncology · 2006 · 350 citations
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Gynecologic Oncology · 2009 · 590 citations
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
Gynecologic Oncology · 2006 · 398 citations
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Gynecologic Oncology · 2006 · 628 citations
References
Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study
Gynecologic Oncology · 2003 · 413 citations
Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective Study
Gynecologic Oncology · 1998 · 515 citations
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
American Journal of Obstetrics and Gynecology · 1994 · 670 citations
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
Journal of Clinical Oncology · 2002 · 2,313 citations
Cancer Statistics, 2003
CA A Cancer Journal for Clinicians · 2003 · 3,295 citations
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Journal of Clinical Oncology · 2003 · 2,051 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.